StockData
Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc. (MRVI) shareholders

MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30170% above fair value
$7.28−0.12 (-1.62%)

Close on Nov 17, 2026Market cap $1.89BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
55.5%
144M of 260M shares
Institutional holders
178
45 new, 23 sold out
Net institutional buying
23M
In Q2 2026
Insider trades, 12 months
2 buys · 2 sales
Net bought $114.54K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
GTCR Investment XI LLC
Joint filing with GTCR Fund XI/B LP (43.83%), Maravai Life Sciences Holdings, LLC (43.83%) and 5 more
130,834,08551.81%13G (passive) amendmentSep 30, 2024
12 West Capital Management LP
Joint filing with Joel Ramin (8.20%)
11,591,3358.20%13G (passive) amendmentDec 31, 2024
BlackRock, Inc.8,580,5535.90%13G (passive) amendmentSep 30, 2025
Israel A. Englander
Joint filing with Millennium Management LLC (5.20%), Millennium Group Management LLC (5.20%)
7,773,1495.20%13G (passive)Sep 22, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of MRVIValueChange% of portfolio
Gtcr LLC20,150,0057.76%$125.74M–3.22%
BlackRock, Inc.9,970,7803.84%$62.22M+625,5120.00%
Braidwell LP8,702,9213.35%$54.31M−1,537,2432.01%
First Eagle Investment Management, LLC7,342,5742.83%$45.82M+4,818,2380.04%
12 West Capital Management LP7,060,1952.72%$44.06M−200,0008.24%
Millennium Management LLC6,508,2202.51%$40.61M+4,858,7300.01%
Vanguard Capital Management LLC5,283,6652.03%$32.97M−166,0370.00%
Ophir Asset Management Pty Ltd4,826,6981.86%$30.12MNew2.48%
Renaissance Technologies LLC4,606,4911.77%$28.74M+341,8020.04%
Deutsche Bank AG\4,304,9271.66%$26.86M+3,446,6720.01%
Geode Capital Management, LLC3,130,2581.21%$19.54M+301,6630.00%
State Street Corp2,901,7061.12%$18.11M+472,9890.00%
Nuveen, LLC2,857,5801.10%$17.83M+2,627,4330.00%
JPMorgan Chase & Co2,593,5591.00%$16.57M+2,236,2990.00%
Two Sigma Investments, LP2,255,8200.87%$14.08M+675,9800.01%
Monaco Asset Management SAM2,231,0260.86%$13.92M−1,189,9941.11%
Prudential Financial Inc2,152,1540.83%$13.43M+2,133,6840.01%
Citadel Advisors LLC2,122,5980.82%$13.25M+638,2790.00%
Point72 Asset Management, L.P.2,005,5790.77%$12.51M−1,199,9170.01%
Morgan Stanley1,908,2760.73%$11.91M−1,411,0490.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026178144M55.5%45 / 5753 / 2344M21M
Q1 2026158121M46.8%28 / 5152 / 2417M18M
Q4 2025159130M50.2%25 / 4557 / 2218M16M
Q3 2025160131M50.4%29 / 4746 / 1812M11M
Q2 2025150130M50.0%20 / 5645 / 5214M16M
Q1 2025184133M51.0%42 / 6151 / 4127M47M
Q4 2024185153M59.0%27 / 6663 / 5728M23M
Q3 2024217148M57.1%47 / 6667 / 3532M22M
Q2 2024206148M56.9%41 / 7270 / 4328M21M
Q1 2024210141M54.4%35 / 7571 / 4720M17M
Q4 2023223138M53.2%55 / 8164 / 3232M30M
Q3 2023205136M52.2%30 / 9756 / 4630M21M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

148 funds held MRVI in Q2 2026, 51% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of MRVIValue% of fundAs of
Vanguard Total Stock Market Index Fund3,706,1031.43%$23.13M0.00%Jun 30, 2026
First Eagle Small Cap Opportunity Fund3,242,3951.25%$21.30M0.73%Jul 31, 2026
iShares Russell 2000 ETF2,969,9031.14%$18.53M0.02%Jun 30, 2026
Nuveen Quant Small Cap Equity Fund1,596,4000.61%$10.49M0.26%Jul 31, 2026
Vanguard Extended Market Index Fund1,455,4240.56%$9.08M0.01%Jun 30, 2026
Meridian Contrarian Fund1,275,0000.49%$7.96M1.17%Jun 30, 2026
Fidelity Small Cap Growth Fund1,264,3800.49%$8.31M0.09%Jul 31, 2026
Fidelity Small Cap Index Fund1,233,6900.48%$8.11M0.02%Jul 31, 2026
iShares Russell 2000 Value ETF1,019,0390.39%$6.36M0.04%Jun 30, 2026
College Retirement Equities Fund - Total Global Stock Account948,5700.37%$5.92M0.00%Jun 30, 2026
iShares Biotechnology ETF741,2180.29%$4.63M0.05%Jun 30, 2026
Fidelity Small Cap Growth K6 Fund659,5100.25%$4.33M0.09%Jul 31, 2026
Fidelity Extended Market Index Fund638,1560.25%$3.06M0.01%May 31, 2026
Schwab U.S. Small-Cap ETF588,8580.23%$2.83M0.01%May 31, 2026
Vanguard Russell 2000 Index Fund560,3140.22%$2.69M0.02%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Bernd BrustChief Executive Officer, Director1,969,5200.76%Nov 12, 2026
Rajesh AsarpotaChief Financial Officer412,5550.16%Nov 2, 2026
Kurt OreshackGeneral Counsel335,7670.13%Jun 10, 2026
Christine DolanSee Remarks425,3180.16%May 22, 2026
Peter Michael LeddySee Remarks727,1770.28%Jul 16, 2025
Kevin HerdeChief Financial Officer674,6360.26%May 28, 2025
William E. Martin IiiChief Executive Officer1,814,6430.70%Mar 19, 2025
Rebecca BuzzeoSee Remarks310,9330.12%Mar 19, 2025
Andrew BurchSee Remarks369,1830.14%Jan 17, 2025
Gregory T. LucierDirector311,2000.12%Jun 10, 2026
Sean Laurence CunninghamDirector184,3480.07%May 28, 2026
R. Andrew EckertDirector412,1830.16%May 28, 2026
Luke Joseph MarkerDirector184,3480.07%May 28, 2026
Susannah GrayDirector216,2000.08%May 28, 2026
Constantine S. MihasDirector184,3480.07%May 28, 2026
John A. DeFordDirector205,4780.08%May 28, 2026
Murali PrahaladDirector154,6070.06%Jun 18, 2025
Jessica HopfieldDirector199,9070.08%Jun 18, 2025
Benjamin James DavermanDirector138,0550.05%Jun 18, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Bernd Brust
Chief Executive Officer, Director
Nov 9, 2026Tax withholding−29,250$7.52$219.96K1,502,749
Rajesh Asarpota
Chief Financial Officer
Oct 30, 2026Tax withholding−5,466$8.46$46.24K286,203
Bernd Brust
Chief Executive Officer, Director
Oct 8, 2026Tax withholding−29,250$7.43$217.33K1,531,999
Rajesh Asarpota
Chief Financial Officer
Sep 30, 2026Tax withholding−5,465$7.65$41.81K418,021
Bernd Brust
Chief Executive Officer, Director
Sep 8, 2026Tax withholding−29,250$7.32$214.11K1,561,249
Rajesh Asarpota
Chief Financial Officer
Aug 31, 2026Tax withholding−5,465$7.68$41.97K423,486
Bernd Brust
Chief Executive Officer, Director
Aug 10, 2026Tax withholding−29,250$6.23$182.23K1,590,499
Rajesh Asarpota
Chief Financial Officer
Jul 30, 2026Tax withholding−5,465$6.59$36.01K428,951
Bernd Brust
Chief Executive Officer, Director
Jul 8, 2026Tax withholding−29,250$5.92$173.16K1,619,749
Rajesh Asarpota
Chief Financial Officer
Jun 30, 2026Tax withholding−65,584$6.39$419.08K434,416
Kurt Oreshack
General Counsel
Jun 10, 2026Sale(10b5-1 plan)−25,000$5.10$127.50K335,767
Gregory T. Lucier
Director
Jun 9, 2026Gift−46,293––155,123
Gregory T. Lucier
Director
Jun 9, 2026Gift+46,293––156,077
Kurt Oreshack
General Counsel
Jun 9, 2026Sale(10b5-1 plan)−25,000$5.06$126.50K360,767
Bernd Brust
Chief Executive Officer, Director
Jun 8, 2026Tax withholding−351,001$5.02$1.76M1,648,999
Constantine S. Mihas
Director
May 26, 2026Award+46,293––184,348
R. Andrew Eckert
Director
May 26, 2026Award+46,293––412,183
Susannah Gray
Director
May 26, 2026Award+46,293––216,200
Gregory T. Lucier
Director
May 26, 2026Award+46,293$4.38$202.76K201,416
Luke Joseph Marker
Director
May 26, 2026Award+46,293––184,348
John A. DeFord
Director
May 26, 2026Award+46,293––205,478
Sean Laurence Cunningham
Director
May 26, 2026Award+46,293––184,348
Gregory T. Lucier
Director
May 26, 2026Award+46,293––201,416
Christine Dolan
See Remarks
May 15, 2026Award+5,006$1.79$8.96K425,318
Kurt Oreshack
General Counsel
May 15, 2026Award+776$2.84$2.20K385,767
Christine Dolan
See Remarks
Mar 16, 2026Tax withholding−28,661$3.08$88.28K420,312
Kurt Oreshack
General Counsel
Mar 16, 2026Tax withholding−39,976$3.08$123.13K384,991
Christine Dolan
See Remarks
Jan 15, 2026Tax withholding−28,934$3.69$106.77K448,973
Kurt Oreshack
General Counsel
Jan 15, 2026Tax withholding−31,902$3.69$117.72K424,967
Gregory T. Lucier
Director
Dec 8, 2025Buy+48,528$3.67$178.10K155,123
Gregory T. Lucier
Director
Dec 5, 2025Buy+51,472$3.70$190.45K106,595
Christine Dolan
See Remarks
Nov 14, 2025Award+4,300$1.79$7.70K477,907
Bernd Brust
Chief Executive Officer, Director
Nov 13, 2025Buy+216,212$3.25$702.69K466,771
Bernd Brust
Chief Executive Officer, Director
Nov 12, 2025Buy+93,358$3.21$299.68K250,559
Bernd Brust
Chief Executive Officer, Director
Nov 11, 2025Buy+157,201$3.24$509.33K157,201
Peter Michael Leddy
See Remarks
Jul 15, 2025Tax withholding−5,154$2.59$13.35K727,177
Gregory T. Lucier
Director
Jul 10, 2025Gift+89,139––109,784
Gregory T. Lucier
Director
Jul 10, 2025Gift−89,139––55,123
Rajesh Asarpota
Chief Financial Officer
Jun 30, 2025Award+500,000––500,000
Sean Laurence Cunningham
Director
Jun 16, 2025Award+89,139$2.16$192.54K138,055
R. Andrew Eckert
Director
Jun 16, 2025Award+231,481$2.16$500.00K365,890
Benjamin James Daverman
Director
Jun 16, 2025Award+89,139$2.16$192.54K138,055
Jessica Hopfield
Director
Jun 16, 2025Award+89,139$2.16$192.54K199,907
John A. DeFord
Director
Jun 16, 2025Award+89,139$2.16$192.54K159,185
Luke Joseph Marker
Director
Jun 16, 2025Award+89,139$2.16$192.54K138,055
Gregory T. Lucier
Director
Jun 16, 2025Award+89,139$2.16$192.54K144,262
Susannah Gray
Director
Jun 16, 2025Award+89,139$2.16$192.54K169,907
Constantine S. Mihas
Director
Jun 16, 2025Award+89,139$2.16$192.54K138,055
Murali Prahalad
Director
Jun 16, 2025Award+89,139$2.16$192.54K154,607
Bernd Brust
Chief Executive Officer, Director
Jun 8, 2025Award+2,000,000––2,000,000
Kevin Herde
Chief Financial Officer
May 15, 2025Award+876$1.67$1.46K674,636
Christine Dolan
See Remarks
May 15, 2025Award+2,381$1.67$3.98K473,607
Kevin Herde
Chief Financial Officer
Mar 17, 2025Tax withholding−8,648$2.64$22.83K279,282
William E. Martin Iii
Chief Executive Officer
Mar 17, 2025Award+986,194––1,814,643
Kevin Herde
Chief Financial Officer
Mar 17, 2025Award+394,478––673,760
Christine Dolan
See Remarks
Mar 17, 2025Award+246,549––471,226
Christine Dolan
See Remarks
Mar 17, 2025Tax withholding−5,336$2.64$14.09K224,677
Peter Michael Leddy
See Remarks
Mar 17, 2025Tax withholding−5,886$2.64$15.54K337,853
Kurt Oreshack
General Counsel
Mar 17, 2025Award+295,858––456,869
Peter Michael Leddy
See Remarks
Mar 17, 2025Award+394,478––732,331

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
5.61%
14M shares short
Days to cover
6.8
At 2M shares a day
Change since last report
+5.3%
From 13M shares
Short volume, 20 days
40.1%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Maravai LifeSciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 104,952 shares on Oct 14, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Kurt Oreshack
Officer
Jun 10, 202625,000$127.50KJun 10, 2026Restricted Stock Vesting
Kurt Oreshack
Officer
Jun 9, 202625,000$126.50KJun 9, 2026Restricted Stock Vesting
Murali Prahalad
Former Director
Dec 23, 20253,951$13.14KDec 23, 2025Restricted Stock Vesting
Jessica Hopfield
Former Director
Dec 19, 202553,951$187.53KDec 19, 2025IPO Shares
Kurt Oreshack
Officer
Jan 31, 202525,000$125.75KJan 31, 2025Restricted Stock Vesting
Maravai Life Sciences Holdings 2, Llc
Owner
May 28, 20241,531,028$16.50MMay 28, 2024Pre-IPO reorganization
Maravai Life Sciences Holdings 2, Llc
Owner
May 28, 20248,409,946$90.66MMay 28, 2024Pre-IPO reorganization

Congress trades

1 trade in Maravai LifeSciences reported by 1 member of the House

MemberTypeTradedAmountFiled
Daniel Goldman
NY10
SoldApr 10, 2023$1K–15KMay 19, 2023

See a number that looks wrong?